WESTFIELD CAPITAL MANAGEMENT CO LP - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 176 filers reported holding ASCENDIS PHARMA A/S in Q4 2020. The put-call ratio across all filers is 1.39 and the average weighting 0.5%.

Quarter-by-quarter ownership
WESTFIELD CAPITAL MANAGEMENT CO LP ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2023$356,035,825
+9.8%
3,802,177
+4.7%
2.42%
+17.8%
Q2 2023$324,130,268
-3.9%
3,631,712
+15.4%
2.06%
-13.6%
Q1 2023$337,327,617
-12.5%
3,146,126
-0.4%
2.38%
-19.9%
Q4 2022$385,707,058
+28.3%
3,158,168
+8.5%
2.98%
+24.6%
Q3 2022$300,561,000
+16.0%
2,910,724
+4.4%
2.39%
+17.0%
Q2 2022$259,201,000
-16.2%
2,788,309
+5.8%
2.04%
+3.0%
Q1 2022$309,247,000
-13.0%
2,635,027
-0.2%
1.98%
-6.2%
Q4 2021$355,285,000
+5.6%
2,640,934
+25.1%
2.11%
+4.0%
Q3 2021$336,551,000
+26.9%
2,111,493
+4.7%
2.03%
+27.8%
Q2 2021$265,195,000
+10.2%
2,015,927
+7.9%
1.59%
+6.1%
Q1 2021$240,708,000
-16.6%
1,867,693
+8.0%
1.50%
-12.6%
Q4 2020$288,510,000
+4.5%
1,729,881
-3.3%
1.71%
-4.3%
Q3 2020$276,198,000
+29.8%
1,789,774
+24.4%
1.79%
+22.2%
Q2 2020$212,779,000
+38.6%
1,438,665
+5.5%
1.46%
+8.2%
Q1 2020$153,526,000
-12.5%
1,363,342
+8.1%
1.35%
+8.2%
Q4 2019$175,396,000
+62.0%
1,260,756
+12.2%
1.25%
+44.1%
Q3 2019$108,269,000
-3.2%
1,124,054
+15.7%
0.87%
+3.0%
Q2 2019$111,897,000
+38.5%
971,752
+41.5%
0.84%
+36.9%
Q1 2019$80,806,000
+139.2%
686,545
+27.3%
0.62%
+113.5%
Q4 2018$33,776,000
-18.1%
539,120
-7.3%
0.29%
-0.3%
Q3 2018$41,222,000
+46.0%
581,734
+37.0%
0.29%
+37.0%
Q2 2018$28,243,000424,5750.21%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q4 2020
NameSharesValueWeighting ↓
RA Capital Management 5,865,338$978,221,00013.68%
Vivo Capital, LLC 1,797,745$299,828,00013.38%
Sofinnova Investments, Inc. 1,109,874$185,105,00011.02%
Avoro Capital Advisors LLC 1,800,000$300,204,0005.17%
Eventide Asset Management 1,704,148$284,218,0004.36%
Stenahm Asset Managment Ltd 29,000$4,837,0004.07%
Ghost Tree Capital, LLC 105,000$17,512,0003.90%
Eversept Partners, LP 187,043$31,195,0323.66%
Spyglass Capital Management LLC 701,594$117,012,0003.59%
Q Global Advisors, LLC 23,183$3,866,0002.72%
View complete list of ASCENDIS PHARMA A/S shareholders